Incyte reports 81% bleed reduction in VWD drug trial data

July 13, 2026 4:00 AM

Incyte (Nasdaq: INCY) presented Phase 1/2 multidose data for its investigational drug latarcibart (VGA039) at the 34th Congress of the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found